US Stocks

Centessa Pharmaceuticals plc

Centessa Pharmaceuticals plc is a UK-based clinical-stage pharmaceutical company that discovers, develops, and delivers medicines to patients with various medical conditions. The company's registrational pipeline products include Lixivaptan and SerpinPC, both undergoing clinical development for the treatment of kidney disease and hemophilia A and B, respectively. Centessa Pharmaceuticals also has a range of emerging and exploratory pipeline products that target other diseases such as pulmonary arterial hypertension, Narcolepsy Type 1, and autoimmune diseases.